Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Bronchiolitis Obliterans Syndrome
×
ibrutinib
×
Clear all
Filters
3
NCT01804686
2026-03-12
CAN3001
Janssen Research & Development, LLC
Phase 3
Recruiting
700 enrolled
NCT01578707
2019-12-18
RESONATEâ„¢
Pharmacyclics LLC.
Phase 3
Completed
391 enrolled
14 charts